This inventor holds 1 USPTO granted patent. Top assignee: Genesis Research & Development Corporation Limited. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Rene Onrust
Introduction
Rene Onrust is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of biotechnology, particularly in the area of compositions isolated from stromal cells. His work has implications for various applications in medical research and treatment.
Latest Patents
Rene Onrust holds a patent for "Compositions isolated from stromal cells and methods for their use." This patent includes isolated polynucleotides encoding polypeptides expressed in mammalian fsn -/- lymph node stromal cells. The patent also provides expression vectors and host cells that comprise such isolated polynucleotides. In certain embodiments, these polynucleotides encode members of the fibroblast growth factor receptor family. Additionally, methods for the use of these polynucleotides and polypeptides are outlined in the patent.
Career Highlights
Rene Onrust is associated with Genesis Research & Development Corporation Limited, where he continues to advance his research and innovations. His work at this company has allowed him to explore the potential of stromal cell compositions in various therapeutic contexts.
Collaborations
Rene has collaborated with notable colleagues such as Anand Kumble and Nevin Abernethy, who have contributed to his research endeavors. Their combined expertise has enhanced the impact of his work in the field.
Conclusion
Rene Onrust's innovative contributions to biotechnology, particularly through his patent on stromal cell compositions, highlight his role as a significant inventor in the industry. His ongoing work at Genesis Research & Development Corporation Limited continues to pave the way for advancements in medical research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
